We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$880B
AUM Growth
+$147B
Cap. Flow
+$97B
Cap. Flow %
11.02%
Top 10 Hldgs %
14.5%
Holding
8,205
New
199
Increased
3,814
Reduced
2,948
Closed
311

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.71B
2
MSFT icon
Microsoft
MSFT
+$3.52B
3
AMZN icon
Amazon
AMZN
+$2.04B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.87B
5
LLY icon
Eli Lilly
LLY
+$1.31B

Sector Composition

Rank Sector Weight
1 Technology 17.3%
2 Healthcare 12.11%
3 Financials 10.63%
4 Consumer Discretionary 8.09%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSBK icon
6101
Bogota Financial
BSBK
$112M
$46.6K ﹤0.01%
4,165
+4,156
+46,178% +$46.9K
CISO
6102
CISO Global
CISO
$11.7M
$46.4K ﹤0.01%
1,213
-322
-21% -$14.6K
TCRR
6103
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$46.3K ﹤0.01%
46,395
-26,853
-37% -$36.2K
MNOV icon
6104
MediciNova
MNOV
$65M
$46.2K ﹤0.01%
22,520
+10,852
+93% +$24K
APT icon
6105
Alpha Pro Tech
APT
$54.8M
$46.1K ﹤0.01%
11,479
-10,909
-49% -$44.5K
IBD icon
6106
Inspire Corporate Bond ETF
IBD
$489M
$46.1K ﹤0.01%
2,000
EMBK
6107
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$46K ﹤0.01%
13,995
-665
-5% -$3.25K
WWR icon
6108
Westwater Resources
WWR
$79.1M
$46K ﹤0.01%
58,205
+16,280
+39% +$17.3K
CGTX icon
6109
Cognition Therapeutics
CGTX
$99.8M
$45.9K ﹤0.01%
21,869
CSCI
6110
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$45.8K ﹤0.01%
3,603
+140
+4% +$2.08K
LGH icon
6111
HCM Defender 500 Index ETF
LGH
$601M
$45.7K ﹤0.01%
1,371
DIVB icon
6112
iShares Core Dividend ETF
DIVB
$1.78B
$45.7K ﹤0.01%
1,218
-763,300
-100% -$28.4M
USVM icon
6113
VictoryShares US Small Mid Cap Value Momentum ETF
USVM
$1.79B
$45.4K ﹤0.01%
721
-7
-1% -$444
QVAL icon
6114
Alpha Architect US Quantitative Value ETF
QVAL
$613M
$45.3K ﹤0.01%
1,409
-32
-2% -$1.07K
BOLT icon
6115
Bolt Biotherapeutics
BOLT
$7.67M
$45.3K ﹤0.01%
1,744
-1,808
-51% -$49.5K
DPRO
6116
Draganfly
DPRO
$174M
$45.2K ﹤0.01%
2,410
+8
+0.3% +$158
CSB icon
6117
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$265M
$45.2K ﹤0.01%
876
+140
+19% +$7.25K
LITS
6118
Lite Strategy Inc
LITS
$29.6M
$45K ﹤0.01%
9,247
+3,504
+61% +$22.8K
AJXA
6119
DELISTED
Great Ajax Corp.7.25% Convertible Senior Notes due 2024
AJXA
$45K ﹤0.01%
1,880
+280
+18% +$6.78K
APM
6120
DELISTED
Aptorum Group
APM
$44.8K ﹤0.01%
8,140
-317
-4% -$2.06K
AWAY icon
6121
Amplify Travel Tech ETF
AWAY
$32.3M
$44.7K ﹤0.01%
2,708
-1,037
-28% -$17K
MAPSW
6122
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$44.5K ﹤0.01%
444,616
DEEF icon
6123
Xtrackers FTSE Developed ex US Multifactor ETF
DEEF
$56.4M
$44.4K ﹤0.01%
1,745
NAIL icon
6124
Direxion Daily Homebuilders & Supplies Bull 3X ETF
NAIL
$577M
$44.3K ﹤0.01%
1,444
+1,048
+265% +$29.2K
EFIV icon
6125
State Street SPDR S&P 500 ESG ETF
EFIV
$1.03B
$44.2K ﹤0.01%
1,207

Similar funds

Morgan Stanley's Q4 2022 Portfolio in Review

As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.

  • Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
  • Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
  • Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
  • Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
  • Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
  • Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
  • Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.